postpartum-hemorrhage

Documents about postpartum-hemorrhage

• Coagulation Factors and Postpartum Hemorrhage#1245286ClinicalTrials.gov
• Safety and Effectiveness of the Alma System in Treating Primary Postpartum Hemorrhage#67714ClinicalTrials.gov
• Carbetocin vs Misoprostol for Postpartum Hemorrhage Prevention#1431481ClinicalTrials.gov
• Postpartum Hemorrhage After Shenghua Decoction Treatment#883776ClinicalTrials.gov
• Balloon Tamponade for Atonic Primary Postpartum Hemorrhage#1443761ClinicalTrials.gov
• Uterine Tamponade for Treatment of Primary Postpartum Hemorrhage#877920ClinicalTrials.gov
• Obstetric Comorbidity Index in Postpartum Hemorrhage#253124ClinicalTrials.gov
• Amr's Maneuver and Postpartum Hemorrhage#801646ClinicalTrials.gov
• Celox™ PPH for Reaching Haemostasis in Patients With Postpartum Hemorrhage#900198ClinicalTrials.gov
• Fever After Misoprostol Administration for the Treatment of Primary Postpartum Hemorrhage#890814ClinicalTrials.gov
• Placental Removal Method And Uterine Massage On Preventing Postpartum Hemorrhage#1093727ClinicalTrials.gov
• The Use of the Bakri Postpartum Balloon in the Management of Postpartum Hemorrhage Refractory to Conservative Measures#1462365ClinicalTrials.gov
• Novel Vacuum-Induced Hemorrhage Control for Postpartum Hemorrhage#888667ClinicalTrials.gov
• Prevention of Postpartum Hemorrhage With Tranexamic Acid#1464336ClinicalTrials.gov
• Prevention of Postpartum Haemorrhage#1259789ClinicalTrials.gov
• Postpartum Video Education#201674ClinicalTrials.gov
• Kenya: The Barriers and Facilitators of Scaling up the Ellavi UBT for Postpartum Hemorrhage#1030339ClinicalTrials.gov
• Ghana: The Barriers and Facilitators of Scaling up the Ellavi UBT for Postpartum Hemorrhage#1138038ClinicalTrials.gov
• Timing of Carbetocin Administration in Postpartum Hemorrhage#1322753ClinicalTrials.gov
• U-CaVIT Versus Standard of Care for Prevention of Atonic Postpartum Hemorrhage After Cesarean Section in High-risk Women.#1261026ClinicalTrials.gov
• Prophylactic Amnioinfusion for Prevention of Postpartum Hemorrhage#1383735ClinicalTrials.gov
• Uterine Preservation With Acar's Atony Suture for Postpartum Uterine Hemorrhage#1212511ClinicalTrials.gov
• Umbilical Cord Drainage to Prevent Postpartum Hemorrhage#1046164ClinicalTrials.gov
• Risk Factors for Postpartum Hemorrhage#862141ClinicalTrials.gov
• Double Simultaneous Uterotonic Agents Versus Single Agent Regimen to Prevent Early Postpartum Hemorrhage#868291ClinicalTrials.gov
• Risk Factors for Postpartum Hemorrhage in Patients With Histologically Verified Placenta Accreta#217160ClinicalTrials.gov
• Prophylactic Tranexamic Acid Reduces Postpartum Hemorrhage#804182ClinicalTrials.gov
• Second-Line Uterotonics in Postpartum Hemorrhage: A Randomized Clinical Trial#873011ClinicalTrials.gov
• Carbetocin Versus Misoprostol in High Risk Patients for Postpartum Hemorrhage After C.S.#884919ClinicalTrials.gov
• Balloon Tamponade Versus Gauze Packing for Postpartum Hemorrhage#1060481ClinicalTrials.gov
• Tranexamic Acid Pharmacokinetics During Postpartum Hemorrhage#810779ClinicalTrials.gov
• Misoprostol for the Treatment of Postpartum Hemorrhage#1138993ClinicalTrials.gov
• Comparison Between Preoperative Vaginal and Postoperative Sublingual Misoprostol for Prevention of Postpartum Hemorrhage During Cesarean Section#1337104ClinicalTrials.gov
• Tranexamic Acid for Postpartum Vaginal Laceration Hemorrhage#1419182ClinicalTrials.gov
• Carbetocin and Oxytocin in Elective Caesarean Section With High Risk of Postpartum Hemorrhage#1485541ClinicalTrials.gov
• Time of Postpartum Hemoglobin Assessment and Blood Loss During Delivery#828454ClinicalTrials.gov
• Effect of Simulation-Based Education on Knowledge, Skills, and Self-Efficacy in Postpartum Hemorrhage Management#1139382ClinicalTrials.gov
• The Effect of Game-Based Learning and Telesimulation on Nursing Students' Management of Postpartum Hemorrhage#807934ClinicalTrials.gov
• Tranexamic Acid for the Prevention of Postpartum Hemorrhage in Pregnant Women With Placenta Previa#856444ClinicalTrials.gov
• Carbetocin Versus Syntometrine for Prevention of Postpartum Hemorrhage After Cesarean Section#865000ClinicalTrials.gov
• Misoprostol and Oxytocin in Uniject® for Postpartum Hemorrhage Prevention in Communities#904976ClinicalTrials.gov
• Prevent Postpartum Hemorrhage in Women With Von Willebrand Disease: The VWD-WOMAN Trial#1381917ClinicalTrials.gov
• The Effect of Skin to Skin Contact on Postpartum Hemorrhage, Pain And Breastfeeding#1451376ClinicalTrials.gov
• Comparison of the Effect of Carbetocin Versus Oxytocin in the Prevention of Postpartum Hemorrhage After Emergency Caesarean Section in Antenatal Low-risk Patients#1173335ClinicalTrials.gov
• RCT of Misoprostol for Postpartum Hemorrhage in India#1338350ClinicalTrials.gov
• Immediate vs Delayed Postpartum Implanon-NXT#861871ClinicalTrials.gov
• Effectiveness of Tranexamic Acid When Used as an Adjunct to Misoprostol for the Treatment of Postpartum Hemorrhage#854176ClinicalTrials.gov
• Carbetocin Uterotonic Treatment in Twin Pregnancies for Prevention of Postpartum Hemorrhage#1262524ClinicalTrials.gov
• Comparing Misoprostol and Oxytocin in UnijectTM for Postpartum Hemorrhage (PPH) Prevention in Mali#1484643ClinicalTrials.gov
• Family history of postpartum hemorrhage is a risk factor for postpartum hemorrhage after vaginal delivery: results from the French prospective multicenter Haemorrhages and Thromboembolic Venous Disease of the Postpartum cohort study#971170HAL (France)